Dalian Bio-Chem Co Ltd (603360) — Strategic Asset Allocation Index
Dalian Bio-Chem Co Ltd (603360) has a Strategic Asset Allocation Index of 42.0% as of June 2023. Strategic assets (PP&E of CN¥614.40 Million plus long-term investments of CN¥-) total CN¥614.40 Million, measured against net assets of CN¥1.46 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Dalian Bio-Chem Co Ltd's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Dalian Bio-Chem Co Ltd Strategic Asset Allocation Index (2011–2021)
This chart shows how Dalian Bio-Chem Co Ltd's Strategic Asset Allocation Index has evolved across 11 annual periods from 2011 to 2021. As of June 2023, the index stands at 42.0%, representing strategic assets of CN¥614.40 Million against net assets of CN¥1.46 Billion CNY. For live market cap and overall valuation, see Dalian Bio-Chem Co Ltd market cap and net worth.
Annual Strategic Asset Allocation Index for Dalian Bio-Chem Co Ltd (2011–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Dalian Bio-Chem Co Ltd from 2011 to 2021, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See shareholders equity of Dalian Bio-Chem Co Ltd for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 78.7% | CN¥825.83 Million | CN¥825.83 Million | CN¥- | CN¥1.05 Billion | ▲ +23.8 pp |
| 2020 | 54.9% | CN¥542.56 Million | CN¥542.56 Million | CN¥- | CN¥988.28 Million | ▲ +1.0 pp |
| 2019 | 53.9% | CN¥557.24 Million | CN¥425.62 Million | CN¥131.61 Million | CN¥1.03 Billion | ▼ -5.1 pp |
| 2018 | 59.0% | CN¥470.76 Million | CN¥340.76 Million | CN¥130.00 Million | CN¥798.03 Million | ▲ +22.5 pp |
| 2017 | 36.5% | CN¥250.31 Million | CN¥250.31 Million | CN¥- | CN¥686.42 Million | ▼ -17.8 pp |
| 2016 | 54.2% | CN¥248.37 Million | CN¥248.37 Million | CN¥- | CN¥458.09 Million | ▼ -20.3 pp |
| 2015 | 74.5% | CN¥268.26 Million | CN¥268.26 Million | CN¥- | CN¥360.17 Million | ▼ -15.0 pp |
| 2014 | 89.5% | CN¥271.41 Million | CN¥271.41 Million | CN¥- | CN¥303.16 Million | ▼ -2.4 pp |
| 2013 | 92.0% | CN¥254.89 Million | CN¥254.89 Million | CN¥- | CN¥277.14 Million | ▼ -15.0 pp |
| 2012 | 107.0% | CN¥244.20 Million | CN¥244.20 Million | CN¥- | CN¥228.22 Million | ▼ -18.8 pp |
| 2011 | 125.8% | CN¥230.75 Million | CN¥230.75 Million | CN¥- | CN¥183.41 Million | — |